Cargando…
WT1 Trio Peptide-Based Cancer Vaccine for Rare Cancers Expressing Shared Target WT1
SIMPLE SUMMARY: Therapeutic options for rare cancers are frequently limited and less effective than for common cancers. Therefore, novel therapeutic strategies to treat rare cancers are urgently required. Our clinical study on rare cancers showed that the biweekly WT1 Trio peptide vaccine comprising...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857088/ https://www.ncbi.nlm.nih.gov/pubmed/36672344 http://dx.doi.org/10.3390/cancers15020393 |